FDA: Keep Taking Vytorin

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

The Food and Drug Administration says patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its review of a controversial study.

The agency is sticking to its original position that medicines
that reduce bad cholesterol benefit patients at risk of heart
attack or stroke.

FDA says it has finished reviewing the study, which compared
Vytorin to one of the combination pill's components, Zocor, that's
available as a much cheaper generic drug.

Last January, the study results showed Vytorin was no better
than Zocor at reducing plaque buildup in arteries. That led some
doctors to urge patients to abandon Vytorin.

Now FDA says patients shouldn't do that, because Vytorin reduced
bad cholesterol more than Zocor.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 37289444 - kake.com/a?a=37289444